HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Coupar, B. E. H. Articles by Both, G. W. Search for Related Content PubMed PubMed Citation Articles by Coupar, B. E. H. Articles by Both, G. W. Agricola Articles by Coupar, B. E. H. Articles by Both, G. W.

Effect of in vitro Mutations in a Vaccinia Virus Early Promoter Region Monitored by Herpes Simplex Virus Thymidine Kinase Expression in Recombinant Vaccinia Virus

¹ Department of Microbiology, John Curtin School of Medical Research, Australian National University, P.O. Box 334, Canberra, A.C.T. 2601
and² CSIRO Division of Molecular Biology, North Ryde, New South Wales 2113, Australia

The location of a promoter (PF) in the HindIII F region of the vaccinia virus genome was mapped by introducing deletions into this region of the DNA. Modified promoters were fused to the herpes simplex virus (HSV) thymidine kinase (TK) gene in plasmids facilitating the construction of recombinant vaccinia viruses, and promoter function was monitored by the ability of such plasmids to rescue TK⁺ vaccinia viruses from cells infected with TK^- virus. Deletions from the 3' end of the promoter region produced mutants for which function was either not inhibited or abolished, allowing the 3' promoter boundary to be defined to within 13 nucleotides. As indicated by the presence of the PF transcript in early RNA and the kinetics of HSV TK expression in recombinant vaccinia viruses, transcription from PF occurred primarily at early times during infection. The major transcript was initiated at a site within 20 nucleotides of the 3' end of the promoter and nine bases upstream of the probable translation initiation codon. In one mutant for which a small but reproducible increase in promoter function was detected, the transcription start site was deleted. Nevertheless, transcription still appeared to begin at the equivalent position with respect to the promoter, despite the altered nucleotide sequence. The location of the start site for the PF transcript indicated that the HSV TK gene, inserted at the BamHI site following the promoter, was preceded by an initiation codon which could potentially attenuate expression of the inserted gene. Conversion of this ATG codon to TAG did not significantly improve HSV TK expression.

Keywords: vaccinia virus early promoter, in vitro mutations, HSV thymidine kinase

Received 9 February 1987; accepted 22 May 1987.

This article has been cited by other articles:

				T. R. Johnson, J. E. Fischer, and B. S. Graham Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine J. Gen. Virol., September 1, 2001; 82(9): 2107 - 2116. [Abstract] [Full Text] [PDF]

				R. J. Jackson, A. J. Ramsay, C. D. Christensen, S. Beaton, D. F. Hall, and I. A. Ramshaw Expression of Mouse Interleukin-4 by a Recombinant Ectromelia Virus Suppresses Cytolytic Lymphocyte Responses and Overcomes Genetic Resistance to Mousepox J. Virol., February 1, 2001; 75(3): 1205 - 1210. [Abstract] [Full Text]

				B. E. H. Coupar, P. G. Oke, and M. E. Andrew Insertion sites for recombinant vaccinia virus construction: effects on expression of a foreign protein J. Gen. Virol., February 1, 2000; 81(2): 431 - 439. [Abstract] [Full Text]

				A. Ramsay, A. Husband, I. Ramshaw, S Bao, K. Matthaei, G Koehler, and M Kopf The role of interleukin-6 in mucosal IgA antibody responses in vivo Science, April 22, 1994; 264(5158): 561 - 563. [Abstract] [PDF]